Imris Inc. announced that a University of South Florida neurosurgical team at Tampa General Hospital (TGH) completed initial cases using its recently installed Visius intraoperative MRI (magnetic resonance imaging) — providing the most advanced surgery and operating suite in the Tampa Bay area. 

April 30, 2014 — Fovia Medical Inc. and Imperial College London, a science-based institution in biomedical research, announced a collaboration to bring High Definition Volume Rendering (HDVR) to minimally invasive robotic surgery.

National Institutes of Health (NIH) researchers have identified gene variants that cause a rare syndrome of sporadic fevers, skin rashes and recurring strokes, beginning early in childhood.

Scripps Health became the first health care provider in Southern California to implant the investigational Nanostim leadless pacemaker, the world's first wireless pacemaker totally implanted in the heart, as part of the Leadless II Clinical Trial.

April 30, 2014 — Celladon Corp. announced its lead product candidate, Mydicar, has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA) for reducing hospitalizations for heart failure in NYHA class III or IV chronic heart failure patients who are NAb negative. Celladon is a clinical-stage biotechnology company developing novel therapies for patients with heart failure and other diseases characterized by SERCA enzyme deficiencies.